Possibia

4953819

Last Update Posted: 2021-07-08

Recruiting status is unknown

All Genders

accepted

18 Years-85 Years

1000 Estimated Participants

No Expanded Access

Observational Study

Does not accept healthy volunteers

Coronary Revascularization in Patients With Dialysis in China

China patients in end stage renal disease receiving maintenance dialysis have a high risk of cardiovascular disease (CVD), with a prevalence of 45.5% approximately, and coronary artery disease (CAD) has been identified as the most common one. It remains unclear that what their treatment status is and whether this group of patients can benefit from revascularization in China. The investigators plan to recruit around 30 hospitals from 7 regions as study centers, which represent different levels of economic development in Mainland China. The detailed information includes demographics, medical history, coronary angiogram, in-hospital treatment and procedures, short-term and long-term outcomes. The aim of the study is to provide the real world knowledge about current status of coronary revascularization and prognosis in patients with CAD and dialysis.

Eligibility

Relevant conditions:

Coronary Artery Disease

Dialysis

Intervention

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

Zhengqin Zhai

zhengqin712@outlook.com

+86 18612511571

Data sourced from ClinicalTrials.gov